Evaluation of the Levels of Salivary Paxillin Oral Premalignant and Malignant Lesions

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 29, 2022

Primary Completion Date

June 20, 2023

Study Completion Date

November 1, 2023

Conditions

Comparison of Salivary Paxillin Levels in OPMLs and OSCC to Healthy Subjects

Interventions

DIAGNOSTIC_TEST

Paxillin biomarker

Paxillin used as a salivary biomarker

Trial Locations (1)

Faculty of Dentistry, Cairo

All Listed Sponsors

collaborator

Olfat Shaker

UNKNOWN

lead

Cairo University

OTHER